Projects per year
Fingerprint Dive into the research topics where Alfredo Torres is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Escherichia coli O157
Medicine & Life Sciences
Enterohemorrhagic Escherichia coli
Medicine & Life Sciences
Burkholderia mallei
Medicine & Life Sciences
Burkholderia pseudomallei
Medicine & Life Sciences
Melioidosis
Medicine & Life Sciences
Escherichia coli
Medicine & Life Sciences
Enteropathogenic Escherichia coli
Medicine & Life Sciences
Glanders
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2009 2021
Optimization of Lead Melioidosis and Glanders Vaccine Formulations
9/28/18 → 9/27/19
Project: Other project
Defining Correlates of Production of a Broad-spectrum Attenuated Burkholderia Vaccine
3/23/17 → 6/22/20
Project: Other project
Glycoconjugate Nanoparticle Vaccines Against Burkholderia Infections
National Inst of Allergy & Infectious Di
6/1/16 → 5/31/21
Project: Other project
Perform Biological Experiments on Bacterial Penistence
Los Alamos National Laboratory
9/1/16 → 11/28/18
Project: Other project
High Affinity Monoclonal Antibodies to the Burkholderla Polysaccharide
6/1/16 → 8/31/17
Project: Other project
Research Output 1995 2019
3
Citations
(Scopus)
Burkholderia pseudomallei ΔtonB Δhcp1 Live Attenuated Vaccine Strain Elicits Full Protective Immunity against Aerosolized Melioidosis Infection
Khakhum, N., Bharaj, P., Myers, J. N., Tapia, D., Kilgore, P. B., Ross, B. N., Walker, D., Endsley, J. & Torres, A., Jan 2 2019, In : mSphere. 4, 1Research output: Contribution to journal › Article
Melioidosis
Burkholderia pseudomallei
Attenuated Vaccines
Immunity
Infection
Development of a gold nanoparticle vaccine against enterohemorrhagic escherichia coli o157:H7
Sanchez-Villamil, J. I., Tapia, D. & Torres, A., Jan 1 2019, In : mBio. 10, 4, e01869-19.Research output: Contribution to journal › Article
Open Access
Enterohemorrhagic Escherichia coli
Escherichia coli O157
Gold
Nanoparticles
Vaccines
Evaluating the role of Burkholderia pseudomallei K96243 toxins BPSS0390, BPSS0395, and BPSS1584 in persistent infection
Ross, B. N., Micheva-Viteva, S., Hong-Geller, E. & Torres, A., Jan 1 2019, (Accepted/In press) In : Cellular Microbiology. e13096.Research output: Contribution to journal › Article
Burkholderia pseudomallei
Burkholderia
Microbial Drug Resistance
Anti-Bacterial Agents
Melioidosis
Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis
Khakhum, N., Bharaj, P., Myers, J. N., Tapia, D., Walker, D., Endsley, J. & Torres, A., Jul 1 2019, In : PLoS neglected tropical diseases. 13, 7, e0007578.Research output: Contribution to journal › Article
Open Access
Burkholderia mallei
Glanders
Melioidosis
Attenuated Vaccines
Humoral Immunity
Increased Mortality in Mice following Immunoprophylaxis Therapy with High Dosage of Nicotinamide in Burkholderia Persistent Infections
Micheva-Viteva, S. N., Ross, B. N., Gao, J., Adikari, S., Zhang, P., Mourant, J. R., Wu, T. H., Werner, J. H., Torres, A. & Hong-Geller, E., Jan 1 2019, In : Infection and Immunity. 87, 1Research output: Contribution to journal › Article
Burkholderia Infections
Niacinamide
Mortality
Anti-Bacterial Agents
Therapeutics